These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6734943)

  • 21. Interactions between glucagon and other counterregulatory hormones during normoglycemic and hypoglycemic exercise in dogs.
    Wasserman DH; Lickley HL; Vranic M
    J Clin Invest; 1984 Oct; 74(4):1404-13. PubMed ID: 6148356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of systemic or intracerebroventricular naloxone injection on basal and 2-deoxy-D-glucose-induced ingestive behavior.
    Pénicaud L; Thompson DA
    Life Sci; 1984 Dec; 35(23):2297-302. PubMed ID: 6503614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human semen inhibits T rosette formation through an opiate mediated mechanism.
    Fabbri A; Gnessi L; Perricone R; De Sanctis G; Moretti C; De Carolis C; Fontana L; Isidori A; Fraioli F
    J Clin Endocrinol Metab; 1985 Apr; 60(4):807-9. PubMed ID: 3156145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous opioid peptide inhibition of the central actions of angiotensin.
    Summy-Long JY; Keil LC; Deen K; Rosella L; Severs WB
    J Pharmacol Exp Ther; 1981 Jun; 217(3):619-29. PubMed ID: 6262492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucagon release after stimulation of the lateral hypothalamic area in rats: predominant beta-adrenergic transmission and involvement of endorphin pathways.
    Helman AM; Giraud P; Nicolaidis S; Oliver C; Assan R
    Endocrinology; 1983 Jul; 113(1):1-6. PubMed ID: 6305629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-endorphin and the endocrine pancreas. Studies in healthy and diabetic human beings.
    Feldman M; Kiser RS; Unger RH; Li CH
    N Engl J Med; 1983 Feb; 308(7):349-53. PubMed ID: 6296674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opiate receptor blockade in man reduces 2-deoxy-D-glucose-induced food intake but not hunger, thirst, and hypothermia.
    Thompson DA; Welle SL; Lilavivat U; Pénicaud L; Campbell RG
    Life Sci; 1982 Aug; 31(9):847-52. PubMed ID: 6294433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid antagonism alters blood glucose homeostasis during exercise in humans.
    Hickey MS; Trappe SW; Blostein AC; Edwards BA; Goodpaster B; Craig BW
    J Appl Physiol (1985); 1994 Jun; 76(6):2452-60. PubMed ID: 7928870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opiate blockade enhances hypoglycemic counterregulation in normal and insulin-dependent diabetic subjects.
    Caprio S; Gerety G; Tamborlane WV; Jones T; Diamond M; Jacob R; Sherwin RS
    Am J Physiol; 1991 Jun; 260(6 Pt 1):E852-8. PubMed ID: 2058661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for a role of endogenous opiates in postprandial somatostatin release.
    Schusdziarra V; Rewes B; Lenz N; Maier V; Pfeiffer EF
    Regul Pept; 1983 Aug; 6(4):355-61. PubMed ID: 6138819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppressive effect of vasopressin on the hyperglycemic response to intracranial injection of 2-deoxy-D-glucose.
    Nagai N; Nagai K; Takezawa K; Chun SJ; Nakagawa H
    Neurosci Lett; 1995 May; 190(3):187-90. PubMed ID: 7637890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of motilin-induced somatostatin release in dogs by naloxone.
    Schick R; Schusdziarra V
    Peptides; 1985; 6(5):861-4. PubMed ID: 2867525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of endogenous opioids and histamine in morphine induced emesis.
    Gupta YK; Bhandari P; Chugh A; Seth SD; Dixit KS; Bhargava KP
    Indian J Exp Biol; 1989 Jan; 27(1):52-4. PubMed ID: 2606522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response of gut glucagon-like immunoreactivity to hypoglycemia in dogs.
    Ohneda A; Sasaki I; Naito H; Toda M; Ohneda M; Koizumi F
    Am J Physiol; 1989 Mar; 256(3 Pt 1):E431-8. PubMed ID: 2646947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of endogenous opioids and central opioid receptors in cerebral cortical blood flow autoregulation.
    Nagamachi K; Shitara K; Yamashita Y; Morita H; Nishida Y; Maeta H; Tanaka S; Hosomi H
    Jpn J Physiol; 1995; 45(1):137-49. PubMed ID: 7650849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional glucose metabolism in mouse brain following ACTH peptides and naloxone.
    Dunn AJ; Hurd RW
    Pharmacol Biochem Behav; 1982 Jul; 17(1):37-41. PubMed ID: 6289360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs.
    Ross G; Lickley L; Vranic M
    Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that carotid bodies play an important role in glucoregulation in vivo.
    Koyama Y; Coker RH; Stone EE; Lacy DB; Jabbour K; Williams PE; Wasserman DH
    Diabetes; 2000 Sep; 49(9):1434-42. PubMed ID: 10969826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. beta-Endorphin-induced hyperglycemia is mediated by increased central sympathetic outflow to adrenal medulla.
    van Loon GH; Appel NM
    Brain Res; 1981 Jan; 204(1):236-41. PubMed ID: 7248753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-endorphin inhibits glucose production in the conscious dog.
    Radosevich PM; Williams PE; McRae JR; Lacy WW; Orth DN; Abumrad NN
    J Clin Invest; 1984 Apr; 73(4):1237-41. PubMed ID: 6323537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.